UPDATE: Piper Sandler Downgrades Tabula Rasa Healthcare (TRHC) to Neutral
- Wall St lackluster ahead of Easter break, eyes sharp Q1 gains
- Home Depot agrees to buy SRS Distribution, sees TAM expanding to $1 trillion
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Stocks head into quarter-end on the up; yen on intervention watch
- Dollar gains on euro with Fed's Waller hawkish on rates
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Timken (TKR) Appoints Tarak Mehta as New CEO
Tabula Rasa Healthcare (TRHC) PT Lowered to $43 at SVB Leerink
February 25, 2021 4:39 AM ESTSVB Leerink analyst Stephanie Davis lowered the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $43.00 (from $47.00) while maintaining a Market Perform rating.... More
Cantor Fitzgerald Downgrades Tabula Rasa Healthcare (TRHC) to Neutral
February 24, 2021 11:21 AM ESTCantor Fitzgerald analyst Steven Halper downgraded Tabula Rasa Healthcare (NASDAQ: TRHC) from Overweight to Neutral with a price target of $40.00.
For an analyst ratings summary and ratings history on Tabula Rasa Healthcare... More